This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Ischemic Stroke
and you are
between 22 and 85
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to demonstrate substantial equivalence of the SOLITAIRE™ FR Revascularization Device (SOLITAIRE™ Device) with a legally marketed device, MERCI Retrieval System® (MERCI® Device). The study will demonstrate safety and efficacy of the SOLITAIRE™ Device in subjects requiring mechanical thrombectomy diagnosed with acute ischemic stroke.

Provided treatments

  • Device: SOLITAIRE™ Device
  • Device: MERCI® Device

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01054560. The sponsor of the trial is Medtronic Neurovascular Clinical Affairs and it is looking for 144 volunteers for the current phase.
Official trial title:
SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study